Medicine and Dentistry
Therapeutic Procedure
100%
Romosozumab
85%
Case Report
85%
Notch
57%
Protein
28%
Bone Density
28%
Bisphosphonate
28%
Gene
28%
Disease Exacerbation
14%
Amino Terminal Sequence
14%
Rare Disease
14%
Nucleotide
14%
Fracture
14%
Procollagen
14%
Femoral Neck
14%
Age
14%
Teriparatide
14%
Acroosteolysis
14%
Bone Disease
14%
Telopeptide
14%
Denosumab
14%
Lumbar Spine
14%
Hip
14%
Nursing and Health Professions
Syndrome
100%
Romosozumab
85%
Inpatient
57%
Osteoporosis
42%
Protein
28%
Bisphosphonic Acid Derivative
28%
Woman
28%
Patient
28%
Bone Density
28%
Practice Guideline
14%
Fracture
14%
Rare Disease
14%
Disease Exacerbation
14%
Hospital
14%
Next Generation Sequencing
14%
Nucleotide
14%
Parathyroid hormone[1-34]
14%
Bone Disease
14%
Procollagen
14%
Telopeptide
14%
Acroosteolysis
14%
Denosumab
14%
Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
100%
Romosozumab
85%
Osteoporosis
42%
Protein
28%
Bisphosphonic Acid Derivative
28%
Disease Exacerbation
14%
Fracture
14%
Procollagen
14%
Bone Disease
14%
Rare Disease
14%
Telopeptide
14%
Parathyroid hormone[1-34]
14%
Denosumab
14%
Acroosteolysis
14%
Biochemistry, Genetics and Molecular Biology
Nested Gene
28%
Mutation
28%
Bone Density
28%
Protein
28%
N-Terminus
14%
Nucleotide
14%
Osteolysis
14%
Next Generation Sequencing
14%
Age
14%
Denosumab
14%